Clinical Trial Update: A Study of Soticlestat as an Add-on Therapy in Children and Adults With Dravet Syndrome or Lennox-Gastaut Syndrome [Phase 3]

View source ↗

Summary

A Phase 3 study of Soticlestat as add-on therapy for children and adults with Dravet syndrome or Lennox-Gastaut syndrome has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dravet Syndrome
• Lennox-gastaut Syndrome

Drugs mentioned

• Soticlestat (soticlestat)

Snippet

Sponsor: Takeda | Conditions: Dravet Syndrome (DS), Lennox Gastaut Syndrome (LGS) | Phase 3 | Status: TERMINATED